Blured Pharmaceuticals Private Limited, a active private limited company, was established on 17 August 2015 in Arcot, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100TN2015PTC101840. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.28 Cr.
It upholds a compliant status. Its leadership includes Jayakumar Sadhanandam (Director), Subramaniyan Balanagarajan (Director). Past directors included Jayakumar Sadhanandam, Ramasamy Kavitha, Arunachalam Muthukkumari. Its latest AGM occurred on 29 September 2024, with the balance sheet filed on 31 March 2024. It is based at Door No 140, Bazaar Street, Vazhaipandal, Ranipet District, Arcot, Tamil Nadu, 632318.
U24100TN2015PTC101840
101840
17 August 2015
₹5.00 Cr
₹3.28 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Blured Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayakumar Sadhanandam | Director | 31 May 2019 | Current |
| Subramaniyan Balanagarajan | Director | 28 Nov 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 04 Oct 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 20 Mar 2024 | Past |
| Pramod Abcsdd | Director | 07 Oct 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Blured Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.85% decrease. The company also saw a substantial fall in profitability, with a 39.07% decrease in profit. The company's net worth dipped by a decrease of 0.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Blured Pharmaceuticals had a public holding of 98.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Blured Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Blured Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blured Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Blured Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records. was documented.
Progress on Blured Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
Subramaniyan Balanagarajan was appointed as a Director was appointed as a Director on 28 Nov 2021 & has been associated with this company since 4 years 4 days . was recorded as a recent event.
Jayakumar Sadhanandam was appointed as a Director was appointed as a Director on 31 May 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.
Blured Pharmaceuticals Private Limited was registered on 17 Aug 2015 with Roc Chennai & aged 10 years 3 months as per MCA records. was recorded as a recent event.
The CIN of Blured Pharmaceuticals Private Limited is U24100TN2015PTC101840.
Blured Pharmaceuticals Private Limited is headquartered at Door No 140, Bazaar Street, Vazhaipandal, Ranipet District, Arcot, Tamil Nadu, 632318.
Blured Pharmaceuticals Private Limited was incorporated on 17 August 2015.
The current directors of Blured Pharmaceuticals Private Limited are
The primary industry of Blured Pharmaceuticals Private Limited is Trade.
Blured Pharmaceuticals Private Limited is unlisted.
The authorized capital of Blured Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹3.28 Cr.
The compliance status of Blured Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX